Pharmacy - Neuro/Psych pharmacology News & Articles

981 The impact of mecp2 loss- or gain-of-function on synaptic plasticity Neuropsychopharmacology, July 26, 2012

982 Variation in the glucocorticoid receptor gene at rs41423247 moderates the effect of prenatal maternal psychological symptoms on child cortisol reactivity and behavior Neuropsychopharmacology, July 26, 2012

983 Effects of inhibitor of κb kinase activity in the nucleus accumbens on emotional behavior Neuropsychopharmacology, July 26, 2012

984 Levetiracetam in the Treatment of Alcohol Dependence: Toward the End of the Story Alcoholism: Clinical and Experimental Research, July 25, 2012    Clinical Article

985 A global measure to assess switching antipsychotic medications in the treatment of schizophrenia Human Psychopharmacology: Clinical and Experimental, July 25, 2012    Clinical Article

986 Tissue Plasminogen Activator and Stroke: Review of the Literature for the Clinician The Journal of Emergency Medicine, July 25, 2012    Clinical Article

987 Effectiveness of aripiprazole in adolescents and young adults with schizophrenia spectrum disorders: comparison of first-episode to recurrent psychosis Early Intervention in Psychiatry, July 25, 2012    Clinical Article

988 Safety and efficacy of combined clozapine-azathioprine treatment in a case of resistant schizophrenia associated with Behcets disease: a 2-year follow-up General Hospital Psychiatry, July 25, 2012    Clinical Article

989 Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes Journal of Psychopharmacology, July 25, 2012    Clinical Article

990 Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers Drug and Alcohol Dependence, July 24, 2012    Clinical Article

991 Critical illness polyneuromyopathy American Journal of Health-System Pharmacy, July 24, 2012

992 Extended treatment with Alzheimer's drugs may provide modest cognitive benefit, study shows Full Text Formulary , July 24, 2012    Clinical Article

993 Mindfulness-Based Cognitive Therapy Improves Polysomnographic and Subjective Sleep Profiles in Antidepressant Users with Sleep Complaints Psychotherapy and Psychosomatics, July 23, 2012    Clinical Article

994 Quality of Life and Adverse Effects of Olanzapine Versus Risperidone Therapy in Patients with Schizophrenia Psychiatric Quarterly, July 23, 2012    Clinical Article

995 The neuroprotective effects of cocoa flavanol and its influence on cognitive performance British Journal of Clinical Pharmacology, July 23, 2012    Clinical Article

996 Mycophenolate mofetil associated with progressive multifocal leukoencephalopathy with successful outcome Full Text Saudi Journal of Kidney Diseases and Transplantation, July 23, 2012

997 Interactive effects of corticotropin-releasing hormone receptor 1 gene and childhood adversity on depressive symptoms in young adults: Findings from a longitudinal study European Neuropsychopharmacology, July 23, 2012    Clinical Article

998 Personalized Treatment of Adult Depression: Medication, Psychotherapy, or both? A Systematic Review Depression and Anxiety, July 20, 2012    Evidence Based Medicine    Clinical Article

999 Plasma ubiquitin-proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b Neurological Research, July 19, 2012    Clinical Article

1000 Headache disorders in children and adolescents: their association with psychological, behavioral, and socio-environmental factors Headache: The Journal of Head and Face Pain, July 19, 2012

1 Evaluation of a Discharge Medication Service on an Acute Psychiatric Unit Hospital Pharmacy, April 8, 2013

2 Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness BMC Medicine, March 19, 2013    Free full text    Review Article
Exclusive Author Commentary

3 Does levodopa accelerate the pathologic process in Parkinson disease brain Neurology, October 11, 2011

4 Does antidepressant medication use affect persistence with diabetes medicines? Pharmacoepidemiology and Drug Safety, March 6, 2013

5 Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia Archives of Pharmacal Research, April 5, 2013    Free full text

6 Newer antipsychotics and upcoming molecules for schizophrenia European Journal of Clinical Pharmacology, April 3, 2013

7 Clonazepam for the Treatment of Panic Disorder Current Drug Targets, February 12, 2013    Review Article

8 Long-Acting Injectable Antipsychotics and the Development of Postinjection Delirium/Sedation Syndrome (PDSS) Clinical Neuropharmacology, April 5, 2013

9 Influence of CYP1A1/CYP1A2 and AHR polymorphisms on systemic olanzapine exposure Pharmacogenetics and genomics, April 17, 2013    Review Article

10 Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study British Medical Journal, April 23, 2013    Free full text

11 Intravenous topiramate: Safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate Epilepsia, April 22, 2013

12 CYP2D6*2 Polymorphism as a Predictor of Failed Outpatient Tramadol Therapy in Postherpetic Neuralgia Patients American Journal of Therapeutics, April 12, 2013

13 Effect of Topiramate Monotherapy on Height in Newly Diagnosed Children With Epilepsy Pediatric Neurology , April 25, 2013

14 Prolonged febrile seizures, clinical characteristics, and acute management Epilepsia, April 5, 2013

15 Guidance for the Discontinuation or Switching of Antidepressant Therapies in Adults Journal of Pharmacy Practice, March 25, 2013    Clinical Guideline

16 Effects of antipsychotic drugs on the duration of interictal psychotic episodes in patients with epilepsy Epilepsy & Behavior, April 2, 2013

17 Effects of pregabalin on sleep in generalized anxiety disorder International Journal of Neuropsychopharmacology, April 2, 2013    Review Article

18 Treatment for Tobacco Dependence: Effect on Brain Nicotinic Acetylcholine Receptor Density Neuropsychopharmacology, March 28, 2013

19 Reboxetine Treatment for Autistic Spectrum Disorder of Pediatric Patients With Depressive and Inattentive/Hyperactive Symptoms: An Open-Label Trial Clinical Neuropharmacology, April 4, 2013

20 The current and potential impact of genetics and genomics on neuropsychopharmacology European Neuropsychopharmacology, April 4, 2013    Review Article